USE OF G(A)-LINOLENIC ACID METABOLITES IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OR PREVENTION OF CANCER

摘要

Cancer in a mammal can be treated or prevented by administering to a mammal in need thereof a cancer inhibiting amount of metabolite(s) of alpha -linolenic acid, such as stearidonic acid (18:4 n-3), eicosatetraenoic acid (20:4 n-3), docosapentaenoic acid (22:5 n-3) and mixtures thereof, especially metabolites including stearidonic acid.